This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Edimer Pharmaceuticals, Inc., Espoirxlhed Sarl. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Christine Kowalczyk-Quintas: Innovator in Genetic Disorder Treatments
Introduction
Christine Kowalczyk-Quintas is a prominent inventor based in Lausanne, Switzerland. She has made significant contributions to the field of genetic disorders, particularly in the treatment of X-linked hypohidrotic ectodermal dysplasia (XLHED). With a total of 3 patents to her name, her work focuses on innovative therapeutic approaches that aim to improve the quality of life for individuals affected by genetic conditions.
Latest Patents
One of her latest patents involves the treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein. This invention relates to methods for the temporal administration of EDA agonists, specifically EDI200. The methods correlate to optimal therapeutic response windows required for the formation of EDA-dependent structures, such as ectodermal appendages. By utilizing these methods, targeted therapeutic dosing and administration regimens can be designed to correct or alter abnormal phenotypes associated with genetic disorders, particularly XLHED.
Career Highlights
Throughout her career, Christine has worked with notable companies in the biotechnology sector. She has been associated with Edimer Pharmaceuticals, Inc. and Espoirxlhed Sàrl. Her work in these organizations has allowed her to advance her research and contribute to the development of innovative treatments for genetic disorders.
Collaborations
Christine has collaborated with esteemed colleagues in her field, including Pascal Schneider and Neil Kirby. These partnerships have fostered a collaborative environment that enhances the research and development of effective therapies.
Conclusion
Christine Kowalczyk-Quintas is a trailblazer in the field of genetic disorder treatments. Her innovative patents and collaborations highlight her commitment to improving therapeutic options for individuals with genetic conditions. Her work continues to inspire advancements in medical science and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile